Cargando…
Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review
Baroreflex activation therapy (BAT) is a possible adjuvant treatment for patients with heart failure with reduced ejection fraction (HFrEF) who remain symptomatic despite optimal medical therapy and may be an alternative therapy in patients with contraindications or drug intolerance. Our aim was to...
Autores principales: | Molina‐Linde, Juan Máximo, Cordero‐Pereda, David, Baños‐Álvarez, Elena, Rosario‐Lozano, Maria Piedad, Blasco‐Amaro, Juan Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567643/ https://www.ncbi.nlm.nih.gov/pubmed/37522644 http://dx.doi.org/10.1002/ehf2.14473 |
Ejemplares similares
-
Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review
por: Schmidt, Rodrigo, et al.
Publicado: (2020) -
Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2017) -
Updates on Baroreflex Activation Therapy and Vagus Nerve Stimulation for Treatment of Heart Failure With Reduced Ejection Fraction
por: Babar, Natasha, et al.
Publicado: (2022) -
Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy
por: Nottebohm, Pia I., et al.
Publicado: (2022) -
Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience
por: Blanco, Carola, et al.
Publicado: (2023)